Breast cancer is the bane of middle-aged to older women, and understanding the side effects of exemestane is crucial in managing this disease. The role of the aromatase enzyme is one of the lesser-known facts of this disease. Its ability to fuel the proliferation of cancer cells in women with breast cancer necessitates a formidable […]
The fight against cancer can take on many forms. Some cancers require treatments that are slightly different in their mechanism of action. Cancers affecting vital organs such as the breast, skin, colon, rectum, and stomach demand unique treatment strategies. One such key player in cancer therapy is Fluorouracil (5-FU), a chemotherapy drug that has demonstrated […]
It’s sensible to panic. When you contract cancer of the blood and lymph, the treatment tends to last longer than most cancers. Leukemias and lymphomas are daunting adversaries, and early intervention is often necessary to turn the tide in this battle. In this blog post, we’ll explore the drug, cytarabine, which has proven to be […]
As many of you know, a cancer that starts in the bone marrow is known as a leukemia. Out of these, the cancers that start in early myeloid cells that eventually become red and white blood cells are called myeloid leukemias. Chronic myeloid leukemia is a long-standing condition where white blood cells may seem normal, […]
Since 2004, Erlotinib has been a leader in the fight against pancreatic and lung cancer. This FDA-approved pharmaceutical marvel revolutionized the NSCLC treatment landscape, and also served to combat the cancerous insulin-producing cells in the pancreas. But what exactly is erlotinib? And how does it navigate the web of cancer treatment concerns? Let’s study the […]
Cancer can also hit the soft tissues of the body. This is chiefly your belly, arms, and legs—but it will also include internal parts like your joints, connective tissues, and blood vessels. Soft-tissue sarcomas have prompted researchers to develop innovative treatments that specifically target their underlying mechanisms. Pazopanib, a tyrosine kinase inhibitor, has emerged as […]
Anyone on this planet has a 40% chance of developing cancer in their lifetime. Bleomycin is a formidable champion in the war against cancer’s uncontrolled proliferation, with the pharmacodynamic capability to disrupt malignant cells in several types of cancer. To be specific, it is more effective against squamous cell carcinomas in the lungs, testicular cancer, […]
A large percentage of breast cancer cases are estrogen-receptor (ER) positive. This means treatment would require disrupting the production of estrogen. Aromatase inhibitors (AIs) are a class of medications primarily used in this treatment, as they block the aromatase enzyme that is responsible for converting androgens into estrogens in postmenopausal women. While AIs have proven […]